ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157.

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|32|3717-3717

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.32, 2014-10, pp. : 3717-3717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer

By  

Current Medicinal Chemistry, Vol. 20, Iss. 1, 2013-01 ,pp. : 144-157

Bentham Science Publishers

Access to resources Recommend Favorite

ADDENDUM: Nutraceuticals for Protection and Healing of Gastrointestinal Mucosa. Romano M, Vitaglione P, Sellitto S, D’Argenio G. Curr Med Chem 2012, 19: 109-117.

By  

Current Medicinal Chemistry, Vol. 21, Iss. 28, 2014-09 ,pp. : 3310-3310

Bentham Science Publishers

Access to resources Recommend Favorite

Akt in Prostate Cancer: Possible Role in Androgen-Independence

By  

Current Drug Metabolism, Vol. 4, Iss. 6, 2003-12 ,pp. : 487-496

Bentham Science Publishers

Access to resources Recommend Favorite

Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-09 ,pp. : 591-604

Bentham Science Publishers

Access to resources Recommend Favorite

Genome-Wide Integrated Analyses of Androgen Receptor Signaling in Prostate Cancer Based on High-Throughput Technology

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 472-480

Bentham Science Publishers

Access to resources Recommend Favorite